- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Par Drugs and Chemicals Limited — Important, 22-08-2026: Updates
22-08-2026 | 05:53 pm
22-08-2026 | 05:53 pm
The Board approved significant remuneration increases for key executives: MD & CEO to ₹0.64 Cr each, and an Independent Director to ₹0.24 Cr annually, pending shareholder vote. Directors were also empowered to lead company investment strategy, including appointing portfolio managers.
No comments yet. Be the first to comment!